97 related articles for article (PubMed ID: 20810563)
1. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice.
Alles N; Soysa NS; Hayashi J; Khan M; Shimoda A; Shimokawa H; Ritzeler O; Akiyoshi K; Aoki K; Ohya K
Endocrinology; 2010 Oct; 151(10):4626-34. PubMed ID: 20810563
[TBL] [Abstract][Full Text] [Related]
2. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats.
Cheng YT; Liao J; Zhou Q; Huo H; Zellmer L; Tang ZL; Ma H; Hong W; Liao DJ
Exp Biol Med (Maywood); 2021 Aug; 246(15):1727-1739. PubMed ID: 33926259
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of osteoblastic bone formation by nuclear factor-kappaB.
Chang J; Wang Z; Tang E; Fan Z; McCauley L; Franceschi R; Guan K; Krebsbach PH; Wang CY
Nat Med; 2009 Jun; 15(6):682-9. PubMed ID: 19448637
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine and a low activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects.
Yao Z; Ayoub A; Srinivasan V; Wu J; Tang C; Duan R; Milosavljevic A; Ebetino F; Frontier A; Boyce B
Res Sq; 2024 May; ():. PubMed ID: 38746138
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotective Effects of Polysaccharide-Enriched Hizikia fusiforme Processing Byproduct In Vitro and In Vivo Models.
Jeong YT; Baek SH; Jeong SC; Yoon YD; Kim OH; Oh BC; Jung JW; Kim JH
J Med Food; 2016 Aug; 19(8):805-14. PubMed ID: 27458685
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation.
Orriss IR; Arnett TR; George J; Witham MD
Exp Cell Res; 2016 Mar; 342(2):166-74. PubMed ID: 26968635
[TBL] [Abstract][Full Text] [Related]
8. Anti-NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice.
Takami K; Okamoto K; Etani Y; Hirao M; Miyama A; Okamura G; Goshima A; Miura T; Kurihara T; Fukuda Y; Kanamoto T; Nakata K; Okada S; Ebina K
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37991021
[TBL] [Abstract][Full Text] [Related]
9. Ethanolic extract from the root and leaf of Sida cordifolia promotes osteoblast activity and prevents ovariectomy-induced bone loss in mice.
Patel K; Mangu SR; Sukhdeo SV; Sharan K
Phytomedicine; 2022 May; 99():154024. PubMed ID: 35263671
[TBL] [Abstract][Full Text] [Related]
10. Myeloid lineage skewing due to exacerbated NF-κB signaling facilitates osteopenia in Scurfy mice.
Chen TH; Swarnkar G; Mbalaviele G; Abu-Amer Y
Cell Death Dis; 2015 Apr; 6(4):e1723. PubMed ID: 25880090
[TBL] [Abstract][Full Text] [Related]
11. Sex differences of NF-κB-targeted therapy for mitigating osteoporosis associated with chronic inflammation of bone.
Toya M; Kushioka J; Shen H; Utsunomiya T; Hirata H; Tsubosaka M; Gao Q; Chow SK; Zhang N; Goodman SB
Bone Joint Res; 2024 Jan; 13(1):28-39. PubMed ID: 38194999
[TBL] [Abstract][Full Text] [Related]
12. Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice.
Wang H; Zhang H; Srinivasan V; Tao J; Sun W; Lin X; Wu T; Boyce BF; Ebetino FH; Boeckman RK; Xing L
J Bone Miner Res; 2020 Feb; 35(2):343-356. PubMed ID: 31610066
[TBL] [Abstract][Full Text] [Related]
13. BMP2-ERK-ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis.
Zhou Z; Zhao C; Li S; Han X; Zhu J; Xue S; Li Z
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542323
[TBL] [Abstract][Full Text] [Related]
14. Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice.
Aljohani H; Stains JP; Majumdar S; Srinivasan D; Senbanjo L; Chellaiah MA
Bone Res; 2021 Apr; 9(1):22. PubMed ID: 33837180
[TBL] [Abstract][Full Text] [Related]
15. Development of epimedin A complex drugs for treating the osteoporosis.
Liu Y; Bi Y; Chai L; Song L; Huang J; Wang Q; Li Y; Zhou K
J Mater Sci Mater Med; 2021 Jan; 32(1):17. PubMed ID: 33506368
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide stimulates osteoblastogenesis and bone formation by inhibiting nuclear factor kappa-Β signaling both
Yongyun C; Jingwei Z; Zhiqing L; Wenxiang C; Huiwu L
J Orthop Translat; 2019 Oct; 19():47-57. PubMed ID: 31844613
[TBL] [Abstract][Full Text] [Related]
17. Rosavin regulates bone homeostasis through HDAC1-induced epigenetic regulation of EEF2.
Zhang W; Yu L; Wang F; Chen M; Li H
Chem Biol Interact; 2023 Oct; 384():110696. PubMed ID: 37689331
[TBL] [Abstract][Full Text] [Related]
18. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis.
Yang YS; Xie J; Wang D; Kim JM; Tai PWL; Gravallese E; Gao G; Shim JH
Nat Commun; 2019 Jul; 10(1):2958. PubMed ID: 31273195
[TBL] [Abstract][Full Text] [Related]
19. Effects of Caffeic Acid and Its Derivatives on Bone: A Systematic Review.
Ekeuku SO; Pang KL; Chin KY
Drug Des Devel Ther; 2021; 15():259-275. PubMed ID: 33519191
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Jumonji domain-containing 1C inhibits the osteogenic differentiation of bone marrow mesenchymal stem cells
Li JY; Wang TT; Ma L; Zhang Y; Zhu D
World J Stem Cells; 2024 Feb; 16(2):151-162. PubMed ID: 38455099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
